Patent · US Active

Antiviral composition and method of use

US10376537B2 · kind B2 · utility

0Cited by

7References

20Claims

0Family size

Assignee

MARINOMED BIOTECH AG · AT

Inventors

Andreas Grassauer · Wien, AT
Eva Prieschl-Grassauer · Wien, AT
Christiane Koller · Seyring, AT
Alexander Pretsch · Großmugl, AT

Key dates

Filing date	Aug 23, 2012
Grant date	Aug 13, 2019
Priority date	—
Expiry date	Aug 23, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein is a method of reducing the risk of a rhinovirus infection, the method includes administering to a subject a composition comprising iota-carrageenan in an antiviral effective amount as an active antiviral ingredient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.